Adapalene
Pricing Report NDC 51672-4155-6

Latest NADAC: $1.71545 per GM · Effective Nov 18, 2020 · Est. package price $77.20 (45 GM)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Adapalene (NDC 51672-4155-6) is $1.71545 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Nov 18, 2020.

As a provided by Taro Pharmaceuticals U.s.a., Inc., this medication is distributed in a 1 TUBE in 1 CARTON / 45 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.71545
Per GM

Pricing Unit
Per GM Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Nov 18, 2020
Billable Units
45 GM
Estimated Package Price
$77.20
Data Status
As of Dec 02, 2020
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
51672-4155-6
Description
1 TUBE in 1 CARTON / 45 g in 1 TUBE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $1.38526 to $2.85812 per GM. Over this 6 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.3853 - $2.8581
Market Volatility
106.32% Variance
Latest Trend
12.51%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Nov 18, 2020 $1.71545 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 21, 2020 $1.52470 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 23, 2020 $1.56214 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 19, 2020 $1.41388 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 22, 2020 $1.58908 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 17, 2020 $1.40881 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 20, 2020 $1.39588 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 22, 2020 $1.54796 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 18, 2020 $1.54592 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 19, 2020 $1.67289 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 22, 2020 $1.46126 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 18, 2019 $1.43608 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026